Abstract
The management of the patients with atrial fibrillation is the global problem of the modern cardiology and internal medicine because of the associated high mortality risk and severe complications. Drug therapy, especially antithrombotic, becomes a difficult question in case of patient with comorbidity conditions. Though there are some new more effective and safe drugs that becomes more popular and convenient for patients. To reduce the amount of thrombotic complications is the main aspect. And only the outpatient departments can provide patients with atrial fibrillation with the adequate antithrombotic prevention. But nowadays this field doesn’t work as it should according to the European and National Guidelines. So this article speaks about alive and dead patients with atrial fibrillation, about their management in out-patient and in-patient department and about the way they should be treated according to Guidelines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
